We accept
The link between Tesamorelina and the treatment of fatty liver in alcoholism (EHGNA) — recently medically reclassified as MASLD (steatotic liver disease associated with metabolic dysfunction) — is currently one of the most promising and active areas of investigation in the field of endocrinology and hepatology.
Even though Tesamorelina (under the brand name Egrifta) was originally approved only for reducing abdominal fat in patients with HIV, researchers quickly discovered that its effects on the liver were extraordinary.
Next, I detail in depth what current scientific research is, how it works and where clinical trials are found.
To understand why scientists are interested in this peptide for fatty liver, we have to look at how the hormone hormone works:
The liver and Growth Hormone (GH): There is a very clear inverse relationship in human biology: patients with growth hormone deficiency tend to accumulate fat in the liver quickly. GH is essential for the liver to oxidize (burn) lipids and function correctly.
The role of Tesamorelina: As a releasing hormone (GHRH), Tesamorelina stimulates the pituitary gland to produce natural and powerful pulses of GH.
The effect of the “Vena Porta”: Tesamorelina is famous for destroying visceral grease (the grease that surrounds the intestines). This grease drains directly into the liver through the pore, bombarding it with toxic free fatty acids. By eliminating visceral grease, Tesamorelina cuts the source of “contaminated” grease from the liver.
The heaviest and most prestigious research on this topic has been led by teams at Massachusetts General Hospital (MGH) and Harvard University, led by researchers such as Dr. Steven Grinspoon.
The results of his placebo-controlled trials revealed very compelling data:
Massive reduction in liver fat: In studies, patients treated with Tesamorelina experienced relative reductions in liver fat (measured with high-precision magnetic resonance imaging) between 32% and 37% in comparison with the placebo group. In many patients, fat levels in the liver have returned to levels considered “healthy” (lower than 5%).
Prevention of fibrosis: Fatty liver is dangerous because, over time, it becomes inflamed (steatohepatitis or NASH) and creates scars (fibrosis), which leads to cirrhosis. Liver biopsies in studies with Tesamorelina demonstrated that soil treatment reduces grease, which in many patients stops the progression of fibrosis or prevents its appearance, something that very few medications achieve.
Improved biomarkers: Blood analysis from clinical trials shows a significant reduction in altered liver enzymes (AST and ALT), which indicates that the liver tissue is suffering from less damage and inflammation.
It is important to make a distinction about where research is currently taking place:
Population with HIV (Approved and probated): Patients with HIV who take antiretroviral medications have a very high risk of developing severe fatty liver. In this population, Tesamorelina has immense clinical support and is considered a highly successful first-line medical intervention to cleanse the liver and reduce lipodystrophy.
General population with EHGNA/NASH (In the investigation phase): The results in patients with HIV were so good that the FDA pushed Phase 2 and Phase 3 clinical trials to test Tesamorelina in “sane” people (without HIV) who suffer from obesity and fatty liver. The results published until now indicate that the peptide works with the same effectiveness in the general population.
If Tesamorelina is effective in eliminating liver fat, why is it not prescribed massively to the entire population? The current investigation puts several brakes on:
Insulin resistance: Fatty liver is closely linked to type 2 diabetes and insulin resistance. As we saw in interaction analysis, raising the growth hormone (the work of Tesamorelina) can raise blood sugar. Researchers have to carefully balance the dosage to cleanse the liver without causing the patient to cross the threshold into diabetes.
Cost and route of administration: Treating fatty liver requires long-term treatments. Tesamorelina requires daily subcutaneous injections at a cost (as a patented medicine) and costs thousands of euros per month, which makes it unfeasible as a generalized public health treatment in the face of more economical options or lifestyle modifications.
Conclusion of the current state
Today, scientific literature considers Tesamorelina as one of the most potent pharmacological agents known to reduce liver fat and stop fibrosis. Although its use for fat liver in the general population continues to be technically off-label (for official label indication) while waiting for more Phase 3 trials, it has become a clinical tool of great value in private anti-aging and metabolic medicine for patients who do not respond to diet and exercise.
SERMORELIN PEPTIDE.
Recommended for improving your health, your well-being and your recovery.
How it works:
Stimulates the pituitary gland to release natural GH, activating the body's physiological production.
For whom is it indicated:
Peopleas con sueño lighto.
Patients with fatigue and low energy.
Men and women older than 30 years.
People looking for gentle anti-aging.
People who want to improve their skin and collagen.
What a improvement:
Deep dream.
Muscle recovery.
Slight increase in muscle mass.
Firmness of the skin.
Energy and vitality.
Sermorelin → smooth and sueño natural GH.
Safe and effective under the supervision of a specialist doctor.
Approved by the FDA.
Tesamorelin peptide.
Powerful for visceral fat and metabolism.
How it works:
Stimulates GH and IGF-1 with greater intensity, improving body composition and reducing persistent abdominal fat.
For whom is it indicated:
Persons with persistent abdominal fat.
Slow metabolism.
From the age of 30-35.
Those looking for performance and aesthetics.
They may find it difficult to gain muscle mass.
What a improvement:
Reduction of visceral fat.
Increase in lean mass.
Deep dream.
Muscle recovery.
Energy and vitality.
Fast metabolism.
Tesamorelin: Visceral fat and metabolism.
Safe and effective under the supervision of a qualified doctor.
Approved by the FDA.
Elamipretide SS-31 peptide.
Mitochondrial peptide: energy, concentration and longevity.
How it works:
It acts directly on the mitochondria, restoring energy efficiency and reducing cellular inflammation.
For whom is it indicated:
Constant fatigue.
Low vitality.
Seniors over 35 years old.
Overworked professionals and sportspeople.
Quienes buscan longevidad.
What a improvement:
ATP energy.
Concentration and mental clarity.
Muscle recovery.
Cellular protection.
Mood and well-being.
Longevity.
SS-31 Mitochondrial energy and deep anti-aging.
Safe and effective if used under the supervision of a qualified doctor.
Approved by the FDA.
Doctor G Medical Excellence: Health, Bienestar and Longevidad
4243 W Hillsboro blvd Coconut Creek, 33073, FL
Phone: +1 (954) 638-1515
| Monday | 09:00 - 17:00 |
| Tuesday | 09:00 - 17:00 |
| Wednesday | 09:00 - 17:00 |
| Thursday | 09:00 - 17:00 Open now |
| Friday | 09:00 - 17:00 |
| Saturday | 09:00 - 17:00 |
| Sunday | Closed |